skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Yttrium Y 90 Monoclonal Antibody BrE-3 (Code C2607)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Yttrium Y 90 Monoclonal Antibody BrE-3

Definition: A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation. (NCI04)

Label: Yttrium Y 90 Monoclonal Antibody BrE-3

NCI Thesaurus Code: C2607 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0935731  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
MOAB BrE-3, Yttrium Y 90
Yttrium Y 90 Monoclonal Antibody BrE-3

External Source Codes: 
PDQ Closed Trial Search ID 38148
PDQ Open Trial Search ID 38148 (check for NCI PDQ open clinical trial info)
UMLS CUI C0935731

Other Properties:
     Name Value (qualifiers indented underneath)
code C2607
Legacy_Concept_Name Yttrium_Y_90_Monoclonal_Antibody_BrE-3
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom